Nonalcoholic fatty liver disease(NAFLD)is one of the most common causes of liver disease,and its incidence rate continues to increase globally. NAFLD includes nonalcoholic steatosis and can further progress to nonalcoholic steatohepatitis, liver cirrhosis,and hepatocellular carcinoma. So far,liver biopsy has been regarded as the “gold standard”for evaluating hepatic steatosis and fibrosis;however,due to the limitations of biopsy in large - scale screening,noninvasive tests used to evaluate various stages of NAFLD have become increasingly important in the diagnosis and prognosis management of patients. This article summarizes the latest advances in diagnosis and evaluation of NAFLD.
CITATION STYLE
Zhang, X., Liu, Y., Wang, W., & Li, R. (2023). Diagnosis and evaluation of nonalcoholic fatty liver disease. Journal of Clinical Hepatology, 39(8), 1780–1788. https://doi.org/10.3969/j.issn.1001-5256.2023.08.003
Mendeley helps you to discover research relevant for your work.